Frost Phillip MD Et Al's Form 4 filing
Opko Health, Inc. (OPK) · filed Aug 10, 2023
- Accession no.
- 0001209191-23-045261
- Filed
- Aug 10, 2023, 6:59 AM ET
- Trade date
- Aug 9, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions. Open-market purchases total $181.8K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Frost Phillip MD Et AlCIK 0000898860 | Director, Officer (CEO & Chairman), 10% Owner |
| Frost Gamma Investments TrustCIK 0001380896 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 9, 2023 | Common Stock | PPurchaseAcquired | +5,405 | $1.81 | +$9,756.03 | 200,687,099 | Indirect | |
| Aug 9, 2023 | Common Stock | PPurchaseAcquired | +20,843 | $1.81 | +$37,725.83 | 200,707,942 | Indirect | |
| Aug 9, 2023 | Common Stock | PPurchaseAcquired | +25,752 | $1.82 | +$46,739.88 | 200,733,694 | Indirect | |
| Aug 9, 2023 | Common Stock | PPurchaseAcquired | +27,800 | $1.82 | +$50,596 | 200,761,494 | Indirect | |
| Aug 9, 2023 | Common Stock | PPurchaseAcquired | +6,389 | $1.83 | +$11,659.93 | 200,767,883 | Indirect | |
| Aug 9, 2023 | Common Stock | PPurchaseAcquired | +13,811 | $1.83 | +$25,274.13 | 200,781,694 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.